AstraZeneca PLC (AZN.L)
-LSE Ticker: 989529/ISIN: GB0009895292 3,428.00 
1.50(0.04%) 24 May 16:35
| Prev Close: | 3,426.50 |
|---|
| Open: | 3,436.50 |
|---|
| Bid: | 3,427.50 |
|---|
| Ask: | 3,428.50 |
|---|
| 1y Target Est: | 49.40 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 3,409.50 - 3,444.50 |
|---|
| 52wk Range: | 2,578.50 - 3,487.50 |
|---|
| Volume: | 1,228,856 |
|---|
| Avg Vol (3m): | 2,344,210 |
|---|
| Market Cap: | 42.85b |
|---|
| P/E (ttm): | 758.24 |
|---|
| EPS (ttm): | 4.52 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in GBp.
Key Statistics
| Forward P/E (1 yr): | 6.82 |
|---|
| P/S (ttm): | 158.58 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 5.29 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 1.17 |
|---|
| Mean Recommendation*: | 3.0 |
|---|
| PEG Ratio (5 yr expected): | -1.24 |
|---|
Business Summary
AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for cardiovascular, gastrointestinal, neuroscience, infection, oncology, and respiratory and inflammation diseases worldwide.
more 